Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Disruption of the NlpD lipoprotein of the plague pathogen Yersinia pestis affects iron acquisition and the activity of the twin-arginine translocation system.

Tidhar A, Levy Y, Zauberman A, Vagima Y, Gur D, Aftalion M, Israeli O, Chitlaru T, Ariel N, Flashner Y, Zvi A, Mamroud E.

PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007449. doi: 10.1371/journal.pntd.0007449. eCollection 2019 Jun.

2.

Post-exposure administration of a Yersinia pestis live vaccine potentiates second-line antibiotic treatment against pneumonic plague.

Zauberman A, Gur D, Levy Y, Aftalion M, Vagima Y, Tidhar A, Chitlaru T, Mamroud E.

J Infect Dis. 2019 May 16. pii: jiz260. doi: 10.1093/infdis/jiz260. [Epub ahead of print]

PMID:
31095689
3.

A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers.

Shifman O, Steinberger-Levy I, Aloni-Grinstein R, Gur D, Aftalion M, Ron I, Mamroud E, Ber R, Rotem S.

Front Microbiol. 2019 Apr 16;10:754. doi: 10.3389/fmicb.2019.00754. eCollection 2019.

4.

Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin.

Falach R, Sapoznikov A, Alcalay R, Aftalion M, Ehrlich S, Makovitzki A, Agami A, Mimran A, Rosner A, Sabo T, Kronman C, Gal Y.

Toxins (Basel). 2018 Nov 12;10(11). pii: E466. doi: 10.3390/toxins10110466.

5.

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague.

Levy Y, Vagima Y, Tidhar A, Aftalion M, Gur D, Nili U, Chitlaru T, Zauberman A, Mamroud E.

NPJ Vaccines. 2018 Oct 19;3:52. doi: 10.1038/s41541-018-0087-z. eCollection 2018.

6.

Rapid Antibiotic Susceptibility Determination for Yersinia pestis Using Flow Cytometry Spectral Intensity Ratio (SIR) Fluorescence Analysis.

Zahavy E, Rotem S, Gur D, Aloni-Grinstein R, Aftalion M, Ber R.

J Fluoresc. 2018 Sep;28(5):1151-1161. doi: 10.1007/s10895-018-2279-3. Epub 2018 Aug 16.

7.

Inhalational Gentamicin Treatment Is Effective Against Pneumonic Plague in a Mouse Model.

Gur D, Glinert I, Aftalion M, Vagima Y, Levy Y, Rotem S, Zauberman A, Tidhar A, Tal A, Maoz S, Ber R, Pass A, Mamroud E.

Front Microbiol. 2018 Apr 24;9:741. doi: 10.3389/fmicb.2018.00741. eCollection 2018.

8.

Total Body Irradiation Mitigates Inflammation and Extends the Therapeutic Time Window for Anti-Ricin Antibody Treatment against Pulmonary Ricinosis in Mice.

Gal Y, Sapoznikov A, Falach R, Ehrlich S, Aftalion M, Kronman C, Sabo T.

Toxins (Basel). 2017 Sep 11;9(9). pii: E278. doi: 10.3390/toxins9090278.

9.

Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague.

Zauberman A, Vagima Y, Tidhar A, Aftalion M, Gur D, Rotem S, Chitlaru T, Levy Y, Mamroud E.

Front Cell Infect Microbiol. 2017 Jun 21;7:277. doi: 10.3389/fcimb.2017.00277. eCollection 2017.

10.

Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.

Zvi A, Rotem S, Zauberman A, Elia U, Aftalion M, Bar-Haim E, Mamroud E, Cohen O.

Vaccine. 2017 Oct 20;35(44):5995-6006. doi: 10.1016/j.vaccine.2017.05.092. Epub 2017 Jun 9.

PMID:
28606812
11.

Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination.

Aloni-Grinstein R, Schuster O, Yitzhaki S, Aftalion M, Maoz S, Steinberger-Levy I, Ber R.

Front Microbiol. 2017 Feb 28;8:312. doi: 10.3389/fmicb.2017.00312. eCollection 2017.

12.

Potent Antiedematous and Protective Effects of Ciprofloxacin in Pulmonary Ricinosis.

Gal Y, Sapoznikov A, Falach R, Ehrlich S, Aftalion M, Sabo T, Kronman C.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7153-7158. Print 2016 Dec.

13.

Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.

Levy Y, Vagima Y, Tidhar A, Zauberman A, Aftalion M, Gur D, Fogel I, Chitlaru T, Flashner Y, Mamroud E.

J Infect Dis. 2016 Sep 15;214(6):970-7. doi: 10.1093/infdis/jiw290. Epub 2016 Jul 11.

PMID:
27402776
14.

A Rapid Molecular Test for Determining Yersinia pestis Susceptibility to Ciprofloxacin by the Quantification of Differentially Expressed Marker Genes.

Steinberger-Levy I, Shifman O, Zvi A, Ariel N, Beth-Din A, Israeli O, Gur D, Aftalion M, Maoz S, Ber R.

Front Microbiol. 2016 May 19;7:763. doi: 10.3389/fmicb.2016.00763. eCollection 2016.

15.

Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague.

Vagima Y, Zauberman A, Levy Y, Gur D, Tidhar A, Aftalion M, Shafferman A, Mamroud E.

PLoS Pathog. 2015 May 14;11(5):e1004893. doi: 10.1371/journal.ppat.1004893. eCollection 2015 May.

16.

Antibody/doxycycline combined therapy for pulmonary ricinosis: Attenuation of inflammation improves survival of ricin-intoxicated mice.

Gal Y, Mazor O, Alcalay R, Seliger N, Aftalion M, Sapoznikov A, Falach R, Kronman C, Sabo T.

Toxicol Rep. 2014 Aug 1;1:496-504. doi: 10.1016/j.toxrep.2014.07.013. eCollection 2014.

17.

YopP-expressing variant of Y. pestis activates a potent innate immune response affording cross-protection against yersiniosis and tularemia [corrected].

Zauberman A, Flashner Y, Levy Y, Vagima Y, Tidhar A, Cohen O, Bar-Haim E, Gur D, Aftalion M, Halperin G, Shafferman A, Mamroud E.

PLoS One. 2013 Dec 16;8(12):e83560. doi: 10.1371/journal.pone.0083560. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/0ec1f217-4e7a-4dee-9a71-1076a3ac73f1.

18.

Early sensing of Yersinia pestis airway infection by bone marrow cells.

Vagima Y, Levy Y, Gur D, Tidhar A, Aftalion M, Abramovich H, Zahavy E, Zauberman A, Flashner Y, Shafferman A, Mamroud E.

Front Cell Infect Microbiol. 2012 Nov 26;2:143. doi: 10.3389/fcimb.2012.00143. eCollection 2012.

19.

T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.

Levy Y, Flashner Y, Tidhar A, Zauberman A, Aftalion M, Lazar S, Gur D, Shafferman A, Mamroud E.

Vaccine. 2011 Sep 16;29(40):6866-73. doi: 10.1016/j.vaccine.2011.07.059. Epub 2011 Jul 29.

PMID:
21803090
20.

The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague.

Tidhar A, Flashner Y, Cohen S, Levi Y, Zauberman A, Gur D, Aftalion M, Elhanany E, Zvi A, Shafferman A, Mamroud E.

PLoS One. 2009 Sep 14;4(9):e7023. doi: 10.1371/journal.pone.0007023.

21.

Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.

Steinberger-Levy I, Zahavy E, Cohen S, Flashner Y, Mamroud E, Aftalion M, Gur D, Ber R.

Adv Exp Med Biol. 2007;603:339-50.

PMID:
17966430
22.

Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Lazar S, Zvi A, Bino T, Ariel N, Velan B, Shafferman A, Cohen S.

Infect Immun. 2004 Feb;72(2):908-15.

23.

Development of an improved selective agar medium for isolation of Yersinia pestis.

Ber R, Mamroud E, Aftalion M, Tidhar A, Gur D, Flashner Y, Cohen S.

Appl Environ Microbiol. 2003 Oct;69(10):5787-92.

24.

A new selective medium provides improved growth and recoverability of Yersinia pestis.

Ber R, Mamroud E, Aftalion M, Gur D, Tidhar A, Flashner Y, Cohen S.

Adv Exp Med Biol. 2003;529:467-8. No abstract available.

PMID:
12756811
25.

Evaluation of protective immunity induced by Yersinia enterocolitica type-III secretion system mutants.

Mamroud E, Flashner Y, Tidhar A, Ber R, Gur D, Aftalion M, Lazar S, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:425-30. No abstract available.

PMID:
12756803
26.

Identification of genes involved in Yersinia pestis virulence by signature-tagged mutagenesis.

Flashner Y, Mamroud E, Tidhar A, Ber R, Aftalion M, Gur D, Zvi A, Ariel N, Velan B, Shafferman A, Cohen S.

Adv Exp Med Biol. 2003;529:31-3. No abstract available.

PMID:
12756723

Supplemental Content

Loading ...
Support Center